![Sushil Patel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sushil Patel
Vorstandsvorsitzender bei
REPLIMUNE GROUP, INC.
Vermögen: 10 Mio $ am 31.05.2026
Profil
Sushil Patel is currently Chief Executive Officer & Director at Replimune Group, Inc. since 2024 and Independent Director at Revolution Medicines, Inc. since 2022.
Formerly, Dr. Patel was Vice President-Franchise & Head-Oncology at Genentech, Inc. from 2018 to 2021.
Education includes an undergraduate degree from the University of Warwick in 1992, a graduate degree from Imperial College London in 1993, and a doctorate from the University of London in 1999.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
REPLIMUNE GROUP, INC. 0,96 % | 18.05.2026 | 747.492 ( 0,96 % ) | 6 Mio $ | 31.05.2026 |
| 18.06.2026 | 24.281 ( 0,01 % ) | 4 Mio $ | 31.05.2026 |
Aktive Positionen von Sushil Patel
| Unternehmen | Position | Beginn |
|---|---|---|
| REPLIMUNE GROUP, INC. | Vorstandsvorsitzender | 01.04.2024 |
| REVOLUTION MEDICINES, INC. | Direktor/Vorstandsmitglied | 16.06.2022 |
Ehemalige bekannte Positionen von Sushil Patel
| Unternehmen | Position | Ende |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01.05.2021 |
Ausbildung von Sushil Patel
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
95
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Warwick
 University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Revolution Medicines, Inc.
 Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products | Health Technology |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
